OKYO Pharma Ltd (OKYO) stock
OKYONasdaqBiological Products, (No Diagnostic Substances)
$1.07−0.09 (-7.76%)
Close on Nov 20, 2026Market cap $56.15MP/E –Yield –
OKYO Pharma gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
No gross profit figures for OKYO Pharma
OKYO Pharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?